Professor Erika Lietzan has again been named a “Best Lawyer in America” in both FDA Law and Biotechnology & Life Sciences. This marks the seventh year in a row for FDA Law and the thirteenth year in a row for Biotechnology Law. The Best Lawyers honor is meant to identify the top 5 percent of practicing attorneys in the United…
Tag: FDA Law ⋅ Page 1
Professor Lietzan speaks at The Federalist Society’s COVID-19 & the Law Conference
Professor Erika Lietzan spoke at The Federalist Society’s COVID-19 & the Law Conference, contributing to the panel Regulation or “Don’t Let a Good Crisis Go to Waste.” She focused on decisions by regulators to de-regulate during the crisis — decisions to exercise enforcement discretion, to waive paperwork requirements, and to remove otherwise applicable restrictions — including decisions made by FDA…
Professor Lietzan Named a “Best Lawyer in America”
Professor Erika Lietzan has again been named a “Best Lawyer in America” in both FDA Law and Biotechnology & Life Sciences. This marks the sixth year in a row for FDA Law and the twelfth year in a row for Biotechnology Law. The Best Lawyers honor is meant to identify the top 5 percent of practicing attorneys in the United…
Professor Lietzan testifies before the U.S. House of Representatives Judiciary Committee
Professor Erika Lietzan testified before the House of Representatives Judiciary Committee on July 27, 2017 in a hearing addressing Antitrust Concerns and the FDA Approval Process. Testimony to House of Representatives Judiciary Committee –…